Purpose To provide evidence-based guidance on the optimum prevention and treatment
approaches in the management of chemotherapy-induced peripheral neuropathies (CIPN) …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

Importance There are no known effective treatments for painful chemotherapy-induced
peripheral neuropathy. Objective To determine the effect of duloxetine, 60 mg daily, on …

Pain is a common problem in cancer survivors, especially in the first few years after
treatment. In the longer term, approximately 5% to 10% of survivors have chronic severe …

Cancer diagnosis and treatment are drastic events for patients and their families. Besides
psychological aspects of the disease, patients are often affected by severe side effects …

Purposes Physical activity is supposed to decrease mortality of colorectal cancer (CRC) and
is suggested to reduce side-effects of the disease and its treatment. However, the …

Introduction Peripheral neuropathies are a prevalent, heterogeneous group of diseases of
the peripheral nervous system. Symptoms are often debilitating, difficult to treat, and usually …

Neurotoxicity caused by traditional chemotherapy and radiotherapy is widely recognized in
patients with cancer. The adverse effects of newer therapeutics, such as biological and …

When peripheral neuropathy occurs due to chemotherapy treatment, it is referred to as
chemotherapy-induced peripheral neuropathy (CIPN). Typically, symptoms are sensory …

Abstract Introduction Peripheral neuropathies (PNPs) encompass a large group of disorders
of heterogeneous origin which can manifest themselves with sensory and/or motor deficits …